ResMed Inc. (RMD) Free cash flow 2017–2026
ResMed Inc. (RMD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$1.6BFY2026 · since FY2017: $351.8M → $1.6B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $1.6B | -0.7% |
| FY2025 | $1.7B | +27.6% |
| FY2024 | $1.3B | +126.9% |
| FY2023 | $573.6M | +165.2% |
| FY2022 | $216.3M | -65.9% |
| FY2021 | $634.0M | -10.3% |
| FY2020 | $706.9M | +81.1% |
| FY2019 | $390.3M | -11.8% |
| FY2018 | $442.4M | +25.8% |
| FY2017 | $351.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice